Compounds > 1-amino-1,3-dicarboxycyclopentane

1-amino-1,3-dicarboxycyclopentane and acamprosate

1-amino-1,3-dicarboxycyclopentane has been researched along with acamprosate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blanchard, JA; Fu, MC; Gibson, DA; Harris, BR; Hart, SR; Holley, RC; Littleton, JM; Pedigo, NW; Prendergast, MA; Rogers, DT	1

Other Studies

1 other study(ies) available for 1-amino-1,3-dicarboxycyclopentane and acamprosate

Article	Year
Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors. Alcoholism, clinical and experimental research, 2002, Volume: 26, Issue:12 Topics: Acamprosate; Animals; Binding Sites; Cycloleucine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Taurine	2002

Article

Year

Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors.

Alcoholism, clinical and experimental research, 2002, Volume: 26, Issue:12

Topics: Acamprosate; Animals; Binding Sites; Cycloleucine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Taurine

2002